NASDAQ:LFMD - Nasdaq - US53216B1044 - Common Stock - Currency: USD
5.46
-2.06 (-27.39%)
The current stock price of LFMD is 5.46 USD. In the past month the price increased by 5.81%. In the past year, price decreased by -25.71%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 36.13 | 36.66B | ||
DOCS | DOXIMITY INC-CLASS A | 56.54 | 13.58B | ||
WAY | WAYSTAR HOLDING CORP | N/A | 7.26B | ||
CERT | CERTARA INC | 33.77 | 2.12B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.98B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 15.03 | 1.83B | ||
SDGR | SCHRODINGER INC | N/A | 1.65B | ||
PHR | PHREESIA INC | N/A | 1.64B | ||
EVH | EVOLENT HEALTH INC - A | 15.8 | 1.22B | ||
HSTM | HEALTHSTREAM INC | 50.58 | 999.88M | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 966.46M | ||
DH | DEFINITIVE HEALTHCARE CORP | 14.47 | 762.50M |
LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The company is headquartered in New York City, New York and currently employs 207 full-time employees. The company went IPO on 2001-07-11. The firm operates through two segments: Telehealth and WorkSimpli. Telehealth segment is engaged in telehealth platform, which integrates a clinician-centric electronic medical record (EMR) system, algorithms for case-load balancing and scheduling, customer relationship management functionality, asynchronous communication, secure synchronous, cloud pharmacy and more. Its technology platform, combined with its 50-state affiliated provider network, enables the management of virtual treatment offerings across various health conditions, including, dermatology, urgent and primary care, chronic care management, dermatology, chronic care management and other. Its WorkSimpli segment offers workplace and document services. This segment offers PDFSimpli an online software as a service platform that allows users to create, edit, convert, sign and share PDF documents.
LIFEMD INC
236 Fifth Avenue, Suite 400
New York City NEW YORK 10022 US
CEO: Justin Schreiber
Employees: 207
Company Website: https://lifemd.com/
Investor Relations: http://ir.lifemd.com/#/
Phone: 18663515907
The current stock price of LFMD is 5.46 USD. The price decreased by -27.39% in the last trading session.
The exchange symbol of LIFEMD INC is LFMD and it is listed on the Nasdaq exchange.
LFMD stock is listed on the Nasdaq exchange.
15 analysts have analysed LFMD and the average price target is 11.96 USD. This implies a price increase of 118.99% is expected in the next year compared to the current price of 5.46. Check the LIFEMD INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
LIFEMD INC (LFMD) has a market capitalization of 236.47M USD. This makes LFMD a Micro Cap stock.
LIFEMD INC (LFMD) currently has 207 employees.
LIFEMD INC (LFMD) has a support level at 5.08 and a resistance level at 8.5. Check the full technical report for a detailed analysis of LFMD support and resistance levels.
The Revenue of LIFEMD INC (LFMD) is expected to grow by 38.86% in the next year. Check the estimates tab for more information on the LFMD EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
LFMD does not pay a dividend.
LIFEMD INC (LFMD) will report earnings on 2025-03-10, after the market close.
LIFEMD INC (LFMD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.64).
The outstanding short interest for LIFEMD INC (LFMD) is 13.37% of its float. Check the ownership tab for more information on the LFMD short interest.
ChartMill assigns a technical rating of 3 / 10 to LFMD. When comparing the yearly performance of all stocks, LFMD is a bad performer in the overall market: 82.21% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to LFMD. Both the profitability and financial health of LFMD have multiple concerns.
Over the last trailing twelve months LFMD reported a non-GAAP Earnings per Share(EPS) of -0.64. The EPS increased by 34.69% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -35.3% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 81% to LFMD. The Buy consensus is the average rating of analysts ratings from 15 analysts.
For the next year, analysts expect an EPS growth of 19.44% and a revenue growth 38.86% for LFMD